PR & Interactive Agencies Vie for Pharma Social Media Campaign Crumbs

Should a PR firm or an interactive marketing agency be in charge of pharma social media campaigns?

Proposed Rules for Physician Payment Sunshine Act

Looming Challenges Cloud Implementation. This article reviews the strategic implications of the Sunshine Act and also presents highlights of the draft regulations rule released by the Centers for Medicare and Medicaid Services on December 15, 2011.

Pharma Marketing News Vol. 10, No. 5: 10 MARCH 2011

Welcome to Volume 10, Issue #5 (10 MARCH 2011) of Pharma Marketing News.

Pharma Spending on Internet, DTC, and Docs

How much money the pharmaceutical industry spends on Internet marketing, direct-to-consumer advertising, and physician detailing are always topics of interest and 2010 was no exception. 2010 was, however, a turning point in bringing more attention to payments made to physicians for speaking, consulting, and research.

Adverse Event Reporting: A Missed Opportunity

When asked what the # 1 concern pharmaceutical marketers have regarding using social media, the adverse event reporting (AER) boogey man is cited most often. The urge to avoid this boogey man at all costs may have more to do with CEO compensation that with fears of rank-an-file marketers.

Pharma Marketing News Vol. 10, No. 11: 21 June 2011

Welcome to Volume 10, Issue #11 (21 JUNE 2011) of Pharma Marketing News.

Pharma SmartPhone/Tablet Apps: Is There a Regulation for That?

Pharmaceutical marketers have jumped on the mobile application bandwagon as more and more companies roll out health-related applications for smartphones and touchpads such as Apple's iPhone and iPad. But will the FDA regulate certain smartphone apps as medical devices? This article discusses the regulatory and other issues associated with pharma developed or sponsored health apps.

The Changing Pharma eDetailing Landscape

A conversation with Monique Levy, VP Research at Manhattan Research, about the changing pharma eDetailing landscape. Ms. Levy discusses how the online pharma promotion landscape has changed, and which types of programs garner the largest audience as well as how the rep relationship is evolving and the role of new technologies such as tablets.

Pharma Marketing News Vol. 10, No. 10: 8 June 2011

Welcome to Volume 10, Issue #10 (8 JUNE 2011) of Pharma Marketing News.

Vast Majority of Drug Ads in Leading Medical Journals Don’t Pass MDs’ Sniff Test!

A study led by Mount Sinai School of Medicine researchers of 192 pharmaceutical advertisements (83 full unique advertisements) in biomedical journals found that only 18 percent (15) were compliant with Food and Drug Administration (FDA) guidelines, and over half failed to quantify serious risks including death.


- Advertisement -